Skip to main content

Ligand Pharmaceuticals Inc

LGNXZ
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000886163

In the last 90 days, Ligand Pharmaceuticals Inc insiders filed 0 open-market purchases and 6 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesLGNDLGNDZLGNYZLGNZZ

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Ligand Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
4 insiders, $16.1M in total
Insiders trading
4
Net value
−$16.1M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Ligand Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Ligand Pharmaceuticals Inc
NameTitleLast reported holdingLast filingFilings, past year
Zimmermann MartineDirector3,782Sep 24, 20263
Reardon AndrewCLO & Secretary36,514Sep 8, 20269
Espinoza OctavioChief Financial Officer27,696Aug 14, 202611
Haas JasonDirector3,981Aug 14, 20263
Davis Todd CChief Executive Officer199,513Jul 6, 20264
Sabba Stephen LDirector33,629Jun 18, 20264
Lamattina John LDirector26,969Jun 12, 20264
Aryeh JasonDirector102,580Jun 12, 20262
Kozarich John WDirector42,622Jun 9, 20269
Gray Nancy RyanDirector8,930Jun 9, 20262
Korenberg Matthew EPresident & COO50,777Sep 24, 20240
Higgins John LDirector417,695Dec 30, 20220
Foehr Matthew WOther: Former Executive Officer162,187Nov 3, 20220
Berkman Charles SOther: Former Executive Officer23,825Nov 3, 20220
Patel SunilOther: Former Director28,820Nov 3, 20220
Boyce SarahOther: Former Director2,892Nov 3, 20220
Cochran Jennifer R.Other: Former Director1,161Nov 3, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 4, 2026 (view filing)Mar 22 daysKozarich John WDirectorSSale−467$200.50−$93.6K−1.1%42.7K after6 lots10b5-1
Mar 5, 2026 (view filing)Mar 32 daysSabba Stephen LDirectorSSale−2.03K$201.50−$409.9K−5.7%33.8K after
Mar 6, 2026 (view filing)Mar 42 daysEspinoza OctavioChief Financial OfficerSSale−13.4K$205.83−$2.76M−38.3%21.7K after11 lots10b5-1
Mar 6, 2026 (view filing)Mar 42 daysReardon AndrewCLO & SecretarySSale−5.00K$206.35−$1.03M−11.9%36.9K after11 lots10b5-1
Mar 13, 2026 (view filing)Mar 112 daysEspinoza OctavioChief Financial OfficerSSale−3.06K$225.00−$687.8K−12.7%21.0K after10b5-1
Mar 25, 2026 (view filing)Mar 232 daysSabba Stephen LDirectorSSale−1.00K$207.87−$207.9K−3.0%32.8K after
Mar 31, 2026 (view filing)Mar 625 daysLateLamattina John LDirectorSSale−2.16K$200.76−$433.8K−6.6%30.7K after
Apr 2, 2026 (view filing)Apr 11 dayReardon AndrewCLO & SecretarySSale−5.00K$201.24−$1.01M−10.8%41.4K after6 lots10b5-1
Apr 2, 2026 (view filing)Apr 11 dayKozarich John WDirectorSSale−467$202.22−$94.4K−1.1%42.3K after5 lots10b5-1
May 4, 2026 (view filing)May 13 daysReardon AndrewCLO & SecretarySSale−5.00K$231.31−$1.16M−10.8%41.4K after7 lots10b5-1
May 14, 2026 (view filing)May 1-1313 daysLateKozarich John WDirectorSSale−2.50K$225.14−$563.1K−5.6%41.8K after7 lots10b5-1
Jun 2, 2026 (view filing)Jun 11 dayReardon AndrewCLO & SecretarySSale−5.00K$227.06−$1.14M−10.8%41.4K after7 lots10b5-1
Jun 12, 2026 (view filing)Jun 102 daysLamattina John LDirectorSSale−4.59K$250.88−$1.15M−14.5%27.0K after4 lots
Jun 12, 2026 (view filing)Jun 10-112 daysAryeh JasonDirectorSSale−5.00K$250.00−$1.25M−4.6%102.6K after2 lots
Jun 15, 2026 (view filing)Jun 123 daysHaas JasonDirectorSSale−6.46K$255.58−$1.65M−56.5%4.98K after2 lots
Jun 18, 2026 (view filing)Jun 162 daysSabba Stephen LDirectorSSale−2.15K$254.00−$544.8K−6.0%33.6K after
Jul 6, 2026 (view filing)5:11 PM ETJul 15 daysReardon AndrewCLO & SecretarySSale−5.00K$313.28−$1.57M−10.7%41.5K after8 lots10b5-1
Aug 4, 2026 (view filing)6:42 PM ETAug 31 dayReardon AndrewCLO & SecretarySSale−5.00K$288.99−$1.44M−10.7%41.5K after10 lots10b5-1
Aug 14, 2026 (view filing)5:04 PM ETAug 122 daysHaas JasonDirectorSSale−7.14K$292.81−$2.09M−64.2%3.98K after
Aug 14, 2026 (view filing)5:05 PM ETAug 122 daysEspinoza OctavioChief Financial OfficerSSale−31.6K$292.07−$9.24M−53.3%27.7K after10b5-1
Sep 8, 2026 (view filing)6:34 PM ETSep 35 daysReardon AndrewCLO & SecretarySSale−5.00K$286.09−$1.43M−12.0%36.5K after5 lots10b5-1
Sep 14, 2026 (view filing)4:59 PM ETSep 104 daysZimmermann MartineDirectorSSale−1.20K$285.00−$342.0K−23.5%3.90K after